RNA Medicines For Cancer

Oncorus is focused on realizing the full promise of IV-administered, self-amplifying RNA medicines to transform outcomes for cancer patients. We believe this modality has the potential to safely and effectively kill tumor cells and stimulate multiple arms of the immune system to better fight cancer.

Selective Replication

Our self-amplifying RNA immunotherapies are designed to selectively replicate in tumor cells.

Potent Destruction

Our self-amplifying RNA immunotherapies are designed to potently destroy tumors from within.

Broad Immune Stimulation

Our self-amplifying RNA immunotherapies are designed to simultaneously stimulate multiple arms of the immune system to maximize a systemic anti-tumor response.

Selectively Self-Amplifying RNA

A key challenge of RNA therapeutics is getting enough RNA to the right place. Our IV-administered, self-amplifying RNA solves this problem and can treat tumors throughout the body.

Herpes Simplex Virus

Intratumoral administration

Selectively Self-Amplifying RNA

View Video Transcript

About Selectively Self-Amplifying RNA Immunotherapy

Combining viruses with an RNA-based approach to fight cancer

View Video Transcript

Motivated To Improve Cancer Outcomes

For our team, the fight against cancer is personal.

We all have known someone who courageously fought a battle against cancer. Our personal stories motivate us each day in our pursuit of new, more effective cancer treatments

Explore our Pipeline

ONCR-021

ONCR-788

ONCR-719

Get To Know Oncorus

WE ARE A GREAT COMPANY.

We work hard, together – because we care deeply, and we know that every day a patient goes without an effective treatment is one day too many. We also have fun – because the work we do is hard.

Learn More